Both in Pharmaceuticals
Anixa Biosciences vs OnKure Therapeutics
Over the past year ANIX returned −26.2% and OKUR returned −23.5%; their daily moves had a correlation of 0.22.
ANIX −26.2% OKUR −23.5%Growth of $1, one year, split-adjusted
| Metric | ANIX | OKUR |
|---|---|---|
| Price | $3.06 | $2.50 |
| Market cap | $106.2M | $101.2M |
| Today | +2.17% | −3.47% |
| 1 month | +3.6% | −4.9% |
| 6 months | +1.8% | −44.7% |
| Year to date | −2.1% | −13.8% |
| 1 year | −26.0% | −26.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.9M | $176.4M |
| Dividend yield | — | — |
| Volatility (60d) | 58.8% | 55.6% |
| Short % of float | 7.4% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).